Based on 1 Customer Validation
Prostaglandin E2 (GMP) is Prostaglandin E2 (HY-101952) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Prostaglandin E2, an inflammatory mediator, is a endogenous hormone-like substance that participate in a wide range of body functions.
For research use only. We do not sell to patients.
- CAS No.: 363-24-6
- Formula: C20H32O5
- Molecular Weight:352.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Endogenous Metabolite Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
1.9 nM
Compound: Prostaglandin E2
|
Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method
Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method
|
[PMID: 26985320] |
| CHO | EC50 |
2.5 nM
Compound: Prostaglandin E2
|
Agonist activity at human EP3 receptor expressed in CHO cells assessed as increase in intracellular calcium level by fluorescence based analysis
Agonist activity at human EP3 receptor expressed in CHO cells assessed as increase in intracellular calcium level by fluorescence based analysis
|
[PMID: 26985320] |
| CHO | EC50 |
3.7 nM
Compound: Prostaglandin E2
|
Agonist activity at human EP1 receptor expressed in CHO cells assessed as increase in intracellular calcium level by fluorescence based analysis
Agonist activity at human EP1 receptor expressed in CHO cells assessed as increase in intracellular calcium level by fluorescence based analysis
|
[PMID: 26985320] |
| CHO | EC50 |
347 nM
Compound: Prostaglandin E2
|
Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method
Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method
|
[PMID: 26985320] |
| CHO | EC50 |
7.5 nM
Compound: Prostaglandin E2
|
Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method
Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF method
|
[PMID: 26985320] |
| HEK293 | EC50 |
3 nM
Compound: PGE2
|
EP4 agonist potency utilizing a stable clone of pSV40-EP4 transfected into HEK293 cells expressing EP4 receptor
EP4 agonist potency utilizing a stable clone of pSV40-EP4 transfected into HEK293 cells expressing EP4 receptor
|
[PMID: 12643927] |
| HEK293 | IC50 |
0.7 nM
Compound: PGE2
|
Inhibitory activity against human EP4 receptor expressed in HEK293 ebna cells
Inhibitory activity against human EP4 receptor expressed in HEK293 ebna cells
|
[PMID: 12643927] |
| HEK293 | EC50 |
0.2 nM
Compound: 1
|
Agonist activity against rat EP2 receptor expressed in HEK293 cells assessed as stimulation of cAMP release
Agonist activity against rat EP2 receptor expressed in HEK293 cells assessed as stimulation of cAMP release
|
[PMID: 19250823] |
| HEK293 | EC50 |
0.7 nM
Compound: 1
|
Agonist activity against rat EP4 receptor expressed in HEK293 cells assessed as stimulation of cAMP release
Agonist activity against rat EP4 receptor expressed in HEK293 cells assessed as stimulation of cAMP release
|
[PMID: 19250823] |
| HEK293 | IC50 |
2.1 nM
Compound: 1
|
Inhibition of rat EP4 receptor expressed in HEK293 cells
Inhibition of rat EP4 receptor expressed in HEK293 cells
|
[PMID: 19250823] |
| HEK293 | IC50 |
5.2 nM
Compound: 1
|
Inhibition of rat EP2 receptor expressed in HEK293 cells
Inhibition of rat EP2 receptor expressed in HEK293 cells
|
[PMID: 19250823] |
| HEK293 | EC50 |
346 nM
Compound: Prostaglandin E2
|
Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay
Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated for 90 mins by beta-galactosidase reporter gene assay
|
[PMID: 26985320] |
| HEK293 | IC50 |
2.6 nM
Compound: PGE2
|
Displacement of [3H]PGE2 from human recombinant prostanoid EP2 receptor expressed in HEK293 cells
Displacement of [3H]PGE2 from human recombinant prostanoid EP2 receptor expressed in HEK293 cells
|
[PMID: 26988801] |
| HEK293 | IC50 |
2.6 x 10-9 M
Compound: PGE2
|
Displacement of [3H]PGE2 from human recombinant EP2 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
Displacement of [3H]PGE2 from human recombinant EP2 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
|
[PMID: 27876250] |
| HEK293 | IC50 |
5.5 x 10-10 M
Compound: PGE2
|
Displacement of [3H]PGE2 from human recombinant EP4 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
Displacement of [3H]PGE2 from human recombinant EP4 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
|
[PMID: 27876250] |
| HEK293 | IC50 |
4 nM
Compound: PGE2
|
Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting
Displacement of [3H]prostaglandin E2 from human EP2 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting
|
[PMID: 29995405] |
| K562 | IC50 |
63 μM
Compound: 3
|
In vitro antiproliferative activity was measured on human leukemia K562 cells
In vitro antiproliferative activity was measured on human leukemia K562 cells
|
10.1016/S0960-894X(00)80372-8 |
Prostaglandin E2 (GMP) (10 nM, supplemented in basic culture medium) blocks Paneth cell formation in cultured human small intestinal organoid (hSIO)[1].
Prostaglandin E2 (GMP) (1 or 10 μM, 24 h ) increases proliferation of undifferentiated NE-4C stem cells[2].
Prostaglandin E2 (GMP) (1 μM, 8 day) promotes the progression of NE-4C stem cell differentiation into neuronal-lineage cells[2].
Prostaglandin E2 (GMP) (1 μM, 6 or 8 day) increases the expression of Cadherin-2 (neurosphere adhesion marker)[2].
Prostaglandin E2 (GMP) (1 μM) enhances hematopoietic stem cells (HSCs) homing, survival, and proliferation[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 363-24-6
-
Appearance Solid
-
Molecular Weight 352.47
-
Formula C20H32O5
-
Color White to off-white
-
SMILES
CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C(C[C@H]1O)=O)C/C=C\CCCC(O)=O
-
Synonyms
PGE2 (GMP); Dinoprostone (GMP)
-
Shipping
Shipping with dry ice.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Solvent & Solubility
DMSO : 100 mg/mL (283.71 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (557 KB)
- English - EN (557 KB)
- Français - FR (557 KB)
- Deutsch - DE (557 KB)
- Norwegian - NO (557 KB)
- Español - ES (557 KB)
- Swedish - SV (557 KB)
- Italian - IT (557 KB)
- Korean - KR (557 KB)
- Portuguese - PT (557 KB)
-
Handling Instructions (2659 KB)
References
[1]. He GW, et al. Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation. Cell Stem Cell. 2022 Sep 1;29(9):1333-1345.e6. [Content Brief]
[2]. Wong CT, et al. Prostaglandin E2 promotes neural proliferation and differentiation and regulates Wnt target gene expression. J Neurosci Res. 2016 Aug;94(8):759-75. [Content Brief]
[3]. Hoggatt J, et al. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 2009 May 28;113(22):5444-55. [Content Brief]
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.8371 mL | 14.1856 mL | 28.3712 mL | 70.9280 mL |
| 5 mM | 0.5674 mL | 2.8371 mL | 5.6742 mL | 14.1856 mL | |
| 10 mM | 0.2837 mL | 1.4186 mL | 2.8371 mL | 7.0928 mL | |
| 15 mM | 0.1891 mL | 0.9457 mL | 1.8914 mL | 4.7285 mL | |
| 20 mM | 0.1419 mL | 0.7093 mL | 1.4186 mL | 3.5464 mL | |
| 25 mM | 0.1135 mL | 0.5674 mL | 1.1348 mL | 2.8371 mL | |
| 30 mM | 0.0946 mL | 0.4729 mL | 0.9457 mL | 2.3643 mL | |
| 40 mM | 0.0709 mL | 0.3546 mL | 0.7093 mL | 1.7732 mL | |
| 50 mM | 0.0567 mL | 0.2837 mL | 0.5674 mL | 1.4186 mL | |
| 60 mM | 0.0473 mL | 0.2364 mL | 0.4729 mL | 1.1821 mL | |
| 80 mM | 0.0355 mL | 0.1773 mL | 0.3546 mL | 0.8866 mL | |
| 100 mM | 0.0284 mL | 0.1419 mL | 0.2837 mL | 0.7093 mL |